Daman D. Langguth
Suite 94, L5 30/30 Chasely St
Auchenflower, QLD 4065, Australia
Auchenflower, QLD 4065, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Monitoring Population Exposure to Low- and No-Calorie Sweeteners via Pooled Urine Analysis.
Journal: Food science & nutrition
Published: November 18, 2025
Trends of Organophosphate Ester Flame Retardant Metabolites in Age- and Sex-Stratified Pooled Australian Urine Samples from the Past Decade (2012-2023).
Journal: Environmental science & technology
Published: May 02, 2025
Identifying Populations with Elevated PFAS Exposure by Targeted Serum Sample Pooling.
Journal: Exposure and health
Published: November 30, 2024
Trends of Benzotriazoles and Benzothiazoles in Australian Pooled Urine Samples from 2012 to 2023.
Journal: Environmental science & technology
Published: October 30, 2024
Spatial variations in per- and polyfluoroalkyl substance concentrations in pooled sera from inland, coastal, and island populations.
Journal: Environmental research
Published: September 16, 2024
Serum concentrations of PFAS across Australian States and Territories.
Journal: International journal of hygiene and environmental health
Published: September 12, 2024
Testing for specific IgE to food allergen mixes - A rash decision.
Journal: Journal of paediatrics and child health
Published: April 26, 2024
Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility.
Journal: BMJ open
Published: December 27, 2023
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.
Journal: Blood
Published: October 11, 2023
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.
Journal: Rheumatology (Oxford, England)
Published: October 11, 2022
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: February 17, 2022
Last Updated: 09/26/2026